Preoperative normovolaemic acute haemodilution (PNAH) helps to reduce blood transfusion requirements in patients undergoing major surgery. PNAH reduces mean packed cell volume (PCV) leading to a decrease in blood viscosity. This in turn increases blood flow, assuming that the Hagen-Poiseuille equation is obeyed. The linear decrease in PCV results in an exponential improvement in the rheological properties of blood, particularly in the PCV range 30-46 %, with conservation of oxygen delivery from increased cardiac output despite the dilutional reduction in blood oxygen capacity [1] . As a result of dilution, blood lost during surgery contains plasma substitute, but fewer cells and plasma elements. The effective loss of blood constituents is thus considerably attenuated. Furthermore, autologous blood can be re-transfused after surgical bleeding has been controlled. In order to maintain normovolemia at reduced PCV, colloid diluents are required for intentional haemodilution.
Preoperative normovolaemic acute haemodilution (PNAH) helps to reduce blood transfusion requirements in patients undergoing major surgery. PNAH reduces mean packed cell volume (PCV) leading to a decrease in blood viscosity. This in turn increases blood flow, assuming that the Hagen-Poiseuille equation is obeyed. The linear decrease in PCV results in an exponential improvement in the rheological properties of blood, particularly in the PCV range 30-46 %, with conservation of oxygen delivery from increased cardiac output despite the dilutional reduction in blood oxygen capacity [1] . As a result of dilution, blood lost during surgery contains plasma substitute, but fewer cells and plasma elements. The effective loss of blood constituents is thus considerably attenuated. Furthermore, autologous blood can be re-transfused after surgical bleeding has been controlled. In order to maintain normovolemia at reduced PCV, colloid diluents are required for intentional haemodilution.
PNAH has two main rationales: first, reduction in transfusion requirements (avoiding the risks of homologous transfusion) and second, improvement in circulatory state, particularly for patients at risk of ischaemia. Four main classes of colloid are used: (1) fractionated human albumin, (2) dextrans, (3) hydroxyethylstarch and (4) gelatins. Distribution, tissue storage, concentration half-life and effects on volume expansion and tissue oxygenation, and the relationship with haemostasis have been investigated for most of the current substitutes, but there is little information on their influence on blood rheology, a critical factor in microcirculatory perfusion. Blood rheology is influenced by quantitative factors, the concentration of red cells and proteins in plasma, but also by qualitative factors such as cell deformability and aggregation. Deformability has been found to be influenced little by pathological or pharmacological conditions.
In contrast, erythrocyte aggregation is commonly modified in certain conditions. It tends to occur at the very low shear rates encountered in the venous circulation, where most thrombi occur. In whole blood, red blood cell aggregation results from crosslinking of cells via interactions of their membranes with plasma fibrinogen, globulins and macromolecules. An energetic equilibrium is set up between the aggregation forces (adhesive properties of the macromolecules, where plasma substitutes operate) and repulsive forces (electrical charges on the red blood cell surface and shear stress). Erythrocyte aggregation is in fact a complex variable because of its relationship with blood flow. Thus any variable modifying red blood cell aggregation may influence tissue perfusion by slowing down circulation and reducing capillary flow.
In this study, we assessed, in patients undergoing elective surgery, the intrinsic rheological effects of different plasma substitutes, chosen from the four major families of plasma substitutes. PNAH is a good condition for the investigation of plasma substitutes ex vivo, in view of the standardized operative conditions, the large volumes of infusion required to attain the desired PCV and the requirement for optimal microcirculatory flow. [2] . Volumes of blood withdrawn were replaced by equivalent volumes of substitutes and re-transfused at the end of surgery.
Patients and methods
Fifty patients were allocated randomly to one of five groups. Incomplete medical records in 10 patients (three in each of the dextran and gelatin groups and one in the human albumin group) were discarded. Each group received a different plasma substitute: 4 % human albumin (HA) (Crts Bordeaux, France); 40 000 molecular weight 3.5 % dextran (Plasmacair) (Dxt 40); 60 000 molecular weight 6 % dextran (Hemodex) (Dxt 60); 6 % hydroxyethylstarch 200 000 (Elohes) (HES) and modified 3 % gelatin (Plasmion) (Gel). The solvent for all solutions was normal saline. Patients given Dxt 40 and Dxt 60 received 20 ml of monovalent hapten dextran (average molecular weight : 1000 Da) (Promit), before infusion of the substitute. PCV was determined during haemodilution in the operating room by a micro-method (Autocrit II, Microspin Anaesthesia). Figure 1 shows the monitoring schedule for the haemodynamic measurements and blood sampling. Haemodynamic and lactic acid measurements were made before induction of anaesthesia and before PNAH (Ta), after induction of anaesthesia and before PNAH (Tb) and half-way through (Tc) and at the end of PNAH (Td). Measurements included: heart rate, mean arterial pressure, cardiac output, a . S Blood samples for laboratory tests (anticoagulated with EDTA for the rheological tests) were obtained before PNAH (T0), at the end of PNAH, which lasted for approximately 30 min (T1), and 1.5 h after the end of PNAH (T2), as there appears to be some latency in haemostatic [3] or rheological [4, 5] effects.
Plasma and blood viscosity were measured at 37 ЊC in a Contraves LS 30 rotational viscometer. Whole blood viscosity was evaluated over a wide range of shear rates (seven shear rates) to cover all physiological conditions, but only "low" (1 s
91
) and "high" (128.5 s
) shear rates are shown in the results. The low shear rate is found in the venous circulation where aggregation mechanisms are predominant, and high shear rates are encountered in the arterial circulation where cell deformability is the predominant mechanism. Plasma, a Newtonian fluid, was examined at a single shear rate (128.5 s
). Because of the primary dependence of whole blood viscosity on PCV, viscosity was calculated at standardized PCV (0.45) according to the mathematical model described by Matrai, Whittington and Ernst Erythrocyte aggregation at 37 ЊC was measured in a Sefam erythro-aggregometer (Vandoeuvre-lesNancy, France) [7] . The main characteristics of the device and the significance and calculation of the variables studied have been described previously [8] . This apparatus measures the change in backscattered light on abrupt cessation of suspensions of red blood cells (at different shear rates). The formation of red blood cell aggregates is indicated by a decrease in the optical signal. Several variables can be derived from the plot of light intensity as a function of time, and we determined: primary aggregation time (PAT), corresponding to the reverse of the slope of the curve between 0.5 and 2 s after cessation of maximum shear. This value decreases with increasing erythro-aggregation; partial disaggregation threshold (PDT) corresponds to dissociation of "rouleaux", and is calculated from the maximum intensity of back-scattered light as a function of shear rate. PDT increases as erythroaggregation increases. The normal ranges for our laboratory have been established from samples taken from 20 normal volunteers (aged 20-60 yr); for PAT and PDT, they are 3 (0.5) s and 55 (10) s 91 respectively.
Erythrocyte deformability was studied using a Technicon helium-neon laser ektacytometer (BayerTechnicon, Tarrytown, New York) combining a concentric viscometer and a light scattering device allowing calculation of an elongation index (EI) reflecting the deformation capacity of erythrocytes subjected to a well-defined shear force [9] . PCV was measured by microcentrifugation (Autocrit II).
Lactic acid was assessed by pyruvate peroxidation (normal range 0.6-2.2 mmol litre
). Plasma proteins have been shown to interfere with the haemorheological tests, and therefore total protein (Lowry method) and fibrinogen (Von Clauss method) were measured.
For each laboratory variable, two-way analysis of variance for repeated measures was carried out to assess the "group", "time" and "group time" effects. The F ratios of the mean squares were calculated with respect to the residual mean of the square, and each ratio was tested against the critical F value (as a function of the different degrees of freedom), to measure the significance of each test. P : 0.05 was considered significant for ANOVA. Values at T1 and T2 were compared with those at T0 in each group of patients using Student's t test for paired samples. Unpaired Student's t test was also used to compare the different substitutes with albumin at each time of sampling.
Results
The mean volumes infused were highly comparable between the groups, despite the intra-group dispersion because of the large inter-individual differences in weight and size. Thus high mean volumes (9 1000 ml) were infused (table 1) . Table 2 shows the rheological variables at different times for the five groups. The results of ANOVA are summarized, indicating the influence of the time of withdrawal, or of the substitute, or both, on the different variables studied. For the whole patient series, time of blood withdrawal influenced most of the variables studied, with the exception of the variables unaffected by dilution, such as viscosity at corrected PCV and the erythrocyte deformability index. The major effect of haemodilution was seen as a decrease in PCV, which had decreased to 26-29 % by the end of the procedure (after careful application of Manel's rule). PCV remained close to this level for at least 90 min. ANOVA did not suggest any differences between the groups.
Plasma viscosity was reduced significantly in the presence of HA and increased significantly in the presence of Dxt 60. Thus ANOVA showed a significant "substitute" effect but no "time" effect resulting from the different effects of the various substitutes at T1 and T2 (hypoviscous (HA) or hyperviscous (Gel, HES, Dxt 60) compared with plasma viscosity). These alterations arise from the direct effect of the intrinsic viscosities of the substitutes on overall plasma viscosity. The measured viscosities of these substitutes are given in table 3.
The elongation index, which reflects erythrocyte deformability, was not influenced by haemodilution. The effects of the blood substitutes on whole blood viscosity were evaluated over the two phases illustrated in figure 2 .
The primary effect of haemodilution was a decrease in PCV, leading to a reduction in whole blood viscosity. HA, Dxt 40 and HES produced the greatest reductions in whole blood viscosity (approximately 70 % of the initial value at low shear rate, and 30-40 % of the initial value at high shear rates), while Dxt 60 and Gel had smaller effects, despite the comparable decrease in PCV. This discrepancy was attributed to the differences in intrinsic viscosities of the substitutes. Comparison of whole blood visco- Figure 1 Monitoring schedule for haemodynamic measurements and blood sampling. Haemodynamic and lactic acid measurements were made before induction of anaesthesia and before PNAH (Ta), after induction of anaesthesia and before PNAH (Tb), and half-way through (Tc) and at the end of PNAH (Td). Blood samples were obtained before PNAH (T0), at the end of PNAH (T1) and 1.5 h after the end of PNAH (T2). sities at corrected PCV, that is at constant PCV at the three times (T0, T1, T2), demonstrated more clearly the differences in intrinsic rheological effects of the different substitutes. The substitutes could be split into two main groups: HA, Dxt 40 and HES induced a dramatic reduction in corrected whole blood viscosity at low shear rates, whereas Dxt 60 and Gel markedly increased viscosity. At high shear rates there was no significant difference between the two groups of substitutes. Thus the major difference in the rheological effects of these substitutes was an effect on erythrocyte aggregation, a process occurring primarily at low shear viscosity. Direct measurement of the characteristics of the erythrocyte aggregates (time to reform after dissociation and the force required to dissociate them) supported the viscosimetric findings. Two of the three substitutes from the first group (HA and Dxt 40), which reduced whole blood viscosity at corrected PCV, tended to increase the primary aggregation time and, to a lesser extent, reduce the forces required to dissociate the aggregates. In contrast, the second group of substitutes (Dxt 60 and Gel) induced hyperaggregation, reflected by the decrease in primary aggregation time for Gel and by variables (mean (SD) ). The roles of the factors "substitutes" and "time" on the different variables were assessed using two-way analysis of variance (; : significant,9 = not significant). The significance of the differences between values at T1 and T2 and those at T0 (Student's t test) were: *P : 0.05, **P : 0.01, ***P : 0.001 the increase in the partial dissociation threshold for both Dxt 60 and Gel. On the other hand, HES reduced whole blood viscosity (either at measured or corrected PCV), but tended to increase erythrocyte aggregation, as demonstrated by the significant increase in partial dissociation threshold observed. ANOVA showed the specific effect of the different substitutes on the variables involved in erythroaggregation, namely low shear rate viscosity at corrected PCV, primary aggregation time and partial dissociation threshold. Some variables that may interfere with the haemorheological test results were measured. Total protein and fibrinogen represent major determinants of plasma viscosity and erythrocyte aggregation, respectively. ANOVA showed a "time of withdrawal" effect but little difference between subgroups. The only difference was a smaller decrease in total protein content in the presence of albumin compared with the other substitutes.
The haemodynamic and metabolic data were analysed in the same way as the laboratory data. These variables obeyed their recognized time course during PNAH. ANOVA revealed few inter-group differences at either the first withdrawal (before anaesthesia and haemodilution) or on withdrawal at the end of haemodilution (T1) (table 4). There was a difference in heart rate between the groups at T1, because of the higher heart rate in the presence of Dxt 60 (compared with HA). Initial heart rate was also higher in this group before haemodilution (Ta), although the difference was not significant. Mean arterial pressure was lower after infusion of gelatin.
The influence of the different substitutes used during PNAH on tissue oxygenation was evaluated from the concentration of lactic acid, which reflects overall cellular oxygenation (table 5). Thus lactic Figure 2 Modification of whole blood viscosity at low shear rate (1 s 91 ) for native (top) and corrected (0.45 bottom) packed cell volume (PCV). Whole blood viscosity decreased as PCV decreased dramatically with haemodilution. The bottom histograms show the dramatic increase in whole blood viscosity at corrected PCV in the presence of Dxt 60 and Gel, demonstrating an intrinsic effect of these substitutes on red blood cell aggregation. Table 4 Haemodynamic data (heart rate (HR), mean arterial pressure (MAP), pulmonary wedge pressure (PWP), cardiac index (CI) and oxygen consumption (VO2) (mean (SD)). One-way ANOVA was used at Ta (before anaesthesia to rule out predilution differences between groups) and at T1 (at the end of haemodilution to assess a substitute effect). 
Discussion
We found that the salient effect of haemodilution was a significant improvement in whole blood rheology reflected by the immediate and sustained decrease in PCV and blood viscosity. The dramatic decrease in PCV was caused mainly by the high volumes infused (more than 1 litre). Albumin was chosen as a reference substitute as it is the closest substitute to plasma, with a homogeneous molecular weight. Because of the PCV value targeted (0.30), the need to maintain predilution blood volume to preserve an appropriate right heart filling pressure prevented us from using Ringer's solution as a control in view of the lack of volume-sustaining capacity of crystalloids.
The main finding was the markedly different effects of the different substitutes on whole blood viscosity as a result of their differing influences on red blood cell aggregation. Measured whole blood viscosity depends primarily on red cell concentration, which evaluated simply by measurement of PCV. Thus the effect of PCV needs to be taken into account in order to assess the other determinants of blood viscosity, such as red blood cell deformability and aggregation. We therefore calculated blood viscosity at a standardized PCV (0.45). Two (HA and Dxt 40) of the five substitutes were shown to improve the rheological properties, and two others (Dxt 60 and Gel) led to significant alterations. Similar results have been obtained by Audibert and colleagues [10] with HA, Dxt 40 and Gel. The low aggregating effect of Dxt 40 in vitro has been reported by Seike and Maeda Shiga [11] . On the other hand, Dxt 60 and Gel have also been shown to facilitate red blood cell aggregation in vitro by reducing the electrostatic repulsive forces after adsorption on the cell membranes [12, 13] .
HES had a less consistent rheological effect with a decrease in low shear rate viscosity at corrected PCV and no change in aggregation time, in spite of increased cohesion of the aggregates (increased PDT). In ASA I patients, Dewachter and colleagues [5] reported no effect on blood viscosity at corrected PCV or on erythrocyte aggregation after infusion of HES 500 ml. Audibert and colleagues [10] observed results similar to ours on erythrocyte aggregation (also measured by the SEFAM instrument) after infusion of 1000 ml. The rheological response to HES may therefore depend on the amount infused. In a similar study in atherosclerotic patients, Ehrly Seebens and Saeger-Lorenz [14] demonstrated an increase in erythro-aggregation in the presence of 10 % HES 200 500 ml (HES 50 g), although no comparable effect was observed in the presence of 6 % HES 200 (HES 30 g). In our study, patients received a mean infusion volume of 1185 ml of 6 % HES 200 (HES 71 g). An increase in red blood cell aggregation may thus occur above a critical concentration. Adding the same proportion of 6 % HES 200 or of autologous plasma to a control blood (final PCV : 0.34) in vitro, there was a marked change in the aggregation variables in the presence of HES with a decrease in the primary aggregation time (1.87 s in the presence of HES vs 2.87 s in the presence of autologous plasma) and an increase in the partial dissociation threshold (97 s 91 vs 47.5 s
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). As aggregation time was unchanged in our ex vivo study in spite of an increased dissociation threshold, there may be qualitative changes in the interactions between red blood cells and HES macromolecules transformed in vivo [15] . Goto and colleagues showed that in dogs, apart from an immediate and slight increase in the electrophoretic mobility of red cells indicating increased electronegativity, HES induced a delayed (after 12 h) reduction in electronegativity [16] . Gelatin has also been shown to interact specifically with plasma proteins such as fibronectin, and so may enhance the formation of bridges between red blood cells [17] .
The rheological alterations and the influence of macromolecules on oxygen diffusion have an overall impact on tissue oxygenation, which should be reflected by the concentration of lactic acid. Changes caused by Dxt 60 were difficult to interpret because of the high initial concentrations of lactic acid in this group, but HES and Gel were found to induce a significant increase in lactic acid concentrations. This could be related to a reduction in oxygen flux to peripheral cells. HES, by increasing the forces required to dissociate the aggregates, might also reduce oxygen flux from red cells to tissues by impeding its diffusion [18] . On the other hand, Gel increased dramatically whole blood viscosity at corrected PCV, enhancing erythrocyte aggregation and capillary plugging. Vicaut and colleagues recently described a significant decrease in the density of perfused capillaries in the presence of hypererythro-aggregation in vivo [19] .
Our data indicated that Dxt 40 and HA were the most efficient substitutes in respect of blood rheology and lactic acid concentrations. The concentrations of lactic acid, an indicator of cellular function, would be worth monitoring during PNAH. The rheological properties of a plasma substitute should be taken into consideration together with its volume expansive action. HES has questionable rheological qualities (partly because of its high substitution ratio) despite its well demonstrated and unchallenged expansive qualities. However, new hydroxyethylstarches with lower substitution ratios (0.4-0.5), equivalent concentration and low molecular weight will soon be available and these new products may demonstrate both acceptable rheological and wide-ranging qualities.
